Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelodysplastic Syndrome MDS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3
Not applicableWithdrawnNCT06581055
What this trial is testing

A Retrospective Study to Describe Real-World Treatment Patterns and Clinical Outcomes Among Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes (MDS)
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Testing effectiveness (Phase 2)Study completedNCT01674985
What this trial is testing

Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 43
Early research (Phase 1)Study completedNCT04139434
What this trial is testing

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

Who this might be right for
AML/MDSCMMLRelapse+3 more
Newave Pharmaceutical Inc 32
Not applicableNo Longer AvailableNCT04484363
What this trial is testing

Expanded Access Program With Pevonedistat (Given With Azacitidine) for Adults With Higher-risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Takeda
Early research (Phase 1)Study completedNCT00380653
What this trial is testing

Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes

Who this might be right for
LeukemiasMyelodysplastic Syndromes
Cyclacel Pharmaceuticals, Inc. 47
Not applicableStudy completedNCT00723112
What this trial is testing

The Role of Erythropoietin in Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome
University of Utah 8
Not applicableStudy completedNCT02320656
What this trial is testing

Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesMyeloproliferative Disorders
Institut Paoli-Calmettes 650
Testing effectiveness (Phase 2)Ended earlyNCT03176277
What this trial is testing

ONO-7475 in Patients With Acute Leukemias

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Ono Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07698080
What this trial is testing

Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaThalassemia+2 more
Hematology department of the 920th hospital 60
Testing effectiveness (Phase 2)Study completedNCT03030183
What this trial is testing

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Ra Pharmaceuticals 3
Not applicableStudy completedNCT02891551
What this trial is testing

An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute
Celgene 209
Early research (Phase 1)Ended earlyNCT04250051
What this trial is testing

Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic SyndromeRecurrent Myeloproliferative Neoplasm+5 more
Northwestern University 2
Testing effectiveness (Phase 2)Ended earlyNCT02712905
What this trial is testing

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 116
Testing effectiveness (Phase 2)Looking for participantsNCT05092451
What this trial is testing

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Who this might be right for
B-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more
M.D. Anderson Cancer Center 80
Early research (Phase 1)UnknownNCT03235973
What this trial is testing

Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute
Institut Paoli-Calmettes 29
Testing effectiveness (Phase 2)Study completedNCT00055653
What this trial is testing

Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07796256
What this trial is testing

Study of SGB-9768 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
PNH - Paroxysmal Nocturnal Hemoglobinuria
Suzhou Sanegene Bio Inc. 24
Early research (Phase 1)Study completedNCT00903422
What this trial is testing

Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)

Who this might be right for
Myelodysplastic Syndrome
GlaxoSmithKline 98
Next Page